Literature DB >> 16902279

Rethinking the dementia diagnoses in a population-based study: what is Alzheimer's disease and what is vascular dementia?. A study from the kungsholmen project.

Hedda Aguero-Torres1, Miia Kivipelto, Eva von Strauss.   

Abstract

OBJECTIVE: To explore the hypothesis that older adults often are affected by more than one disease, making the differential diagnosis between Alzheimer's disease (AD) and vascular dementia (VaD) difficult.
METHODS: Incident dementia cases (n = 308) from a population-based longitudinal study of people 75+ years were investigated. The DSM-III-R criteria were used for the clinical diagnosis of dementia. Data on vascular disorders (hypertension, cerebrovascular and ischemic heart diseases, heart failure, atrial fibrillation, diabetes) as well as type of onset/course of dementia were used retrospectively to reclassify dementias.
RESULTS: Only 47% of the AD cases were reclassified as pure AD without any vascular disorder. Among subjects with AD and with a vascular component, cerebrovascular disease was the most common (41%). Only 25% of VaD were reclassified as pure VaD. Further, 26% of the pure AD subjects developed a vascular disorder in the following 3 years.
CONCLUSIONS: Both vascular and degenerative mechanisms may often contribute to the expression of dementia among the elderly. Most of the AD cases have vascular involvements, and pure dementia types in very old subjects constitute only a minority of dementia cases. Copyright (c) 2006 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2006        PMID: 16902279     DOI: 10.1159/000094973

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  25 in total

1.  Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia.

Authors:  Ulrika K Eriksson; Anna M Bennet; Margaret Gatz; Paul W Dickman; Nancy L Pedersen
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

Review 2.  Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

Authors:  Romina M Uranga; Annadora J Bruce-Keller; Christopher D Morrison; Sun Ok Fernandez-Kim; Philip J Ebenezer; Le Zhang; Kalavathi Dasuri; Jeffrey N Keller
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

3.  Perspective: silent, but preventable, perils.

Authors:  Antoine M Hakim
Journal:  Nature       Date:  2014-06-26       Impact factor: 49.962

4.  The Effect of Vascular Neuropathology on Late-life Cognition: Results from the SMART Project.

Authors:  R J Kryscio; E L Abner; P T Nelson; D Bennett; J Schneider; L Yu; L S Hemmy; K O Lim; K Masaki; N Cairns; C Xiong; R Woltjer; H H Dodge; S Tyas; D W Fardo; W Lou; L Wan; F A Schmitt
Journal:  J Prev Alzheimers Dis       Date:  2016-06

5.  Age-associated reductions in cerebral blood flow are independent from regional atrophy.

Authors:  J Jean Chen; H Diana Rosas; David H Salat
Journal:  Neuroimage       Date:  2010-12-16       Impact factor: 6.556

Review 6.  [Treatment and care strategies for Alzheimer's disease and related dementias].

Authors:  H Förstl
Journal:  Nervenarzt       Date:  2008-05       Impact factor: 1.214

7.  Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study.

Authors:  W L Xu; E von Strauss; C X Qiu; B Winblad; L Fratiglioni
Journal:  Diabetologia       Date:  2009-03-12       Impact factor: 10.122

8.  Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later.

Authors:  Alina Solomon; Miia Kivipelto; Benjamin Wolozin; Jufen Zhou; Rachel A Whitmer
Journal:  Dement Geriatr Cogn Disord       Date:  2009-08-04       Impact factor: 2.959

9.  Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer's disease: an open-label trial.

Authors:  Pedro J Modrego; Consuelo Rios; José M Pérez Trullen; Maria J García-Gómara; José M Errea
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

10.  Diffusion tensor imaging of the brain in patients with Alzheimer's disease and cerebrovascular lesions.

Authors:  Shao-qiong Chen; Zhuang Kang; Xi-quan Hu; Bing Hu; Yan Zou
Journal:  J Zhejiang Univ Sci B       Date:  2007-04       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.